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Abstract
Background: Hyperglycaemic emergencies are common acute complications of diabetes mellitus
(DM) but unfortunately, there is a dearth of published data on this entity from Nigeria. This study
attempts to describe the clinical and laboratory scenario associated with this complication of DM.
Methods: This study was carried out in DM patients who presented to an urban hospital in Nigeria
with hyperglycaemic emergencies (HEs). The information extracted included biodata, laboratory
data and hospitalization outcome. Outcome measures included mortality rates, case fatality rates
and predictive factors for HEs mortality. Statistical tests used are χ2, Student's t test and logistic
regression.
Results: A total of 111 subjects with HEs were recruited for the study. Diabetes ketoacidosis
(DKA) and hyperosomolar hyperglycaemic state (HHS) accounted for 94 (85%) and 17 (15%)
respectively of the HEs. The mean age (SD) of the subjects was 53.9 (14.4) years and their ages
ranged from 22 to 86 years. DKA occurred in all subjects with type 1 DM and 73 (81%) of subjects
with type 2 DM. The presence of HSS was noted in 17 (19%) of the subjects with type 2 DM.
Hypokalaemia (HK) was documented in 41 (37%) of the study subjects. Elevated urea levels and
hyponatraemia were noted more in subjects with DKA than in those subjects with HHS
(57.5%,19% vs 53%,18%). The mortality rate for HEs in this report is 20% and the case fatality rates
for DKA and HHS are 18% and 35% respectively.
The predictive factors for HEs mortality include, sepsis, foot ulceration, previously undetected DM,
hypokalaemia and being elderly.
Conclusion: HHS carry a higher case fatality rate than DKA and the predictive factors for
hyperglycaemic emergencies' mortality in the Nigerian with DM include foot ulcers, hypokalaemia
and being elderly.
Published: 10 March 2009
BMC Endocrine Disorders 2009, 9:9 doi:10.1186/1472-6823-9-9
Received: 26 November 2008
Accepted: 10 March 2009
This article is available from: http://www.biomedcentral.com/1472-6823/9/9
© 2009 Ogbera et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Endocrine Disorders 2009, 9:9 http://www.biomedcentral.com/1472-6823/9/9
Page 2 of 5
(page number not for citation purposes)
Background
Diabetes mellitus is a chronic metabolic disorder that is
gradually assuming pandemic proportions. It has been
projected that this emerging scenario will be more evident
in the developing world specifically African and Asian
continents [1,2].
DM is often associated with a high disease burden espe-
cially in areas where there is poor accessibility to health
facilities. Diabetes mellitus is one of the non communica-
ble diseases associated with high case fatality rates in
Africa[3].
Diabetic ketoacidosis (DKA) and hyperosmolar, hypergly-
caemic state (HHS) are acute complications of diabetes
mellitus that may be life threatening if not properly
treated[4]. Diabetic ketoacidosis (DKA) – a triad of hyper-
glycaemia, hyperketonaemia and metabolic acidosis is the
commonest hyperglycaemic emergency of DM [5-7] and
often results in high morbidity and mortality rates. The
treatment of HEs often involves the usage of significant
healthcare resources[5].
In Nigeria, the brunt of the costs of health care provision
is borne largely by the patients and family members.
Given this scenario, the impact of an increasing preva-
lence of DM and its' associated complications in Nigeria
will expectedly result in an unacceptably high disease bur-
den.
HEs are important causes of DM deaths in Nigeria[3]
hence we undertook to document the clinical, laboratory
correlates and mortality rates associated with this all-
important DM complication in our practice.
Methods
This was a prospective study carried out in an urban hos-
pital in Lagos, Nigeria with the study period spanning
over six months. Patients with DM and those that had not
previously been diagnosed with DM, aged above 12 years
of age and presenting in hyperglycaemic emergencies were
recruited for the study. The information extracted
included biodata, plasma glucose and electrolye levels at
presentation, duration of DM, previous treatment type
prior to admission, and mortality data. The presence of
ketones was determined by the detection of ketonuria
using ketostix.
Operational definitions
Duration of DM was categorized into short term dura-
tion, which referred to those that have had DM for less
than 10 years, medium term duration, which referred to
DM duration of 10–19 years and long term duration refer-
ring to DM duration of = 20 years
Diabetes ketoacidosis referred to blood glucose levels
>13.8 mmol/L and the presence of metabolic acidosis
(bicarbonate levels of <10 mmol/L-18 mmol/L) and or
the presence of ketonaemia or ketonuria [8,9].
Hyperosmolar hyperglycaemic state referred to plasma
glucose levels of >33.3 mmol/L and bicarbonate levels of
>18 mmolL with or without the presence of ketonuria
[8,9].
Type 1 DM – Type I DM referred to DM patients who have
been on insulin since diagnosis and require insulin for
survival.
Type 2 DM – Type 2 DM refers to patients with DM who
were previously managed on sole lifestyle modification,
or on oral hypoglycaemic agents. It also encompasses
insulin requiring patients who initially were not insulin
dependent.
Hypernatraemia and hyponatraemia referred to serum
sodium levels of >145 mmol/L and < 136 mmol/L respec-
tively[8].
Hypokalaemia and hyperkalaemia referred to serum
potassium levels of <3.5 mol/L and >5 mmol/L respec-
tively[8].
Urea levels were considered elevated if the blood urea
nitrogen was >7.9 mmol/L[8].
The primary outcome measure was death and the predic-
tive factors for this were studied. Mortality and case fatal-
ity rates for the hyperglycaemic emergencies were
computed and compared in three age groups viz- the low-
est recorded age up to 34 years (Young), those that were
aged between 35 – 64 years (Middle aged) and those who
were aged = 65 years (Elderly).
The Statistic tests used included Student's t test and χ2 for
analysis of quantitative and qualitative data respectively.
The determinants of hyperglycaemic emergecncies' associ-
ated mortality were determined using logistic regression.
Significance level was set at a p value <0.05. The Statistical
package used for analysis was SPSS version 15.
Consent for the study was given by the Research and Eth-
ics Committee of the hospital.
Results
A total of 111 subjects with hyperglycaemic emergencies
were studied. The subjects comprised 21 (19%)and 90
(81%) people with types 1 and 2 DM respectively.BMC Endocrine Disorders 2009, 9:9 http://www.biomedcentral.com/1472-6823/9/9
Page 3 of 5
(page number not for citation purposes)
DKA accounted for 94 (85%) and HHS for 17 (15%) of
the hyperglycaemic emergencies.
Biodata and clinical characteristics of subjects presenting 
with hyperglycaemic emergencies
The mean age (SD) of the study subjects was 53.9 (14.4)
and their ages ranged from 22–86 years. The mean (age)
of the females and that for males were comparable (51.8
(14.4) years vs 55.9 (14.3) years, p > 0.05). The mean
(SD) age of subjects with type 1 DM was significantly
lower than that of those with type 2 DM (40.5(17) years
vs 57.1(11,7)years, p value > 0.001). The male: female
ratio of subjects with type 1 DM was 1:1.3 while that of
type 2 DM was 1: 1.2.
The mean blood glucose and duration of DM of the study
subjects were 25.1 (8) mmol/L and 6.8 (9.4) years respec-
tively. The mean (SD) plasma glucose for females and that
for males were comparable (26.2 (8.6)mol/L vs 24.2 (7.3)
mmol/L p > 0.05). The mean (SD) plasma glucose in sub-
jects with types 1 and 2 DM were 28.2 (7.8)mmol/L and
24.5 (7.2)mmol/L respectively.
Hypertension was noted in 6 (29%) of subjects with type
1 DM and 28 (31%) of those with type 2DM but this dif-
ference was not statistically significant p > 0.05).
15 (14%) of the subjects did not have a prior history of
DM and had the diagnosis of DM made at presentation
with hyperglycaemic emergency.
DKA occurred in all subjects with type 1 DM (21) and 73
(81%) of subjects with type 2 DM. 17 (19%) subjects with
type 2 DM had HHS.
Hypokalaemia was documented in 41 (37%) of the sub-
jects with HEs and hyperkalaemia only in subjects with
DKA -2 (2.1%). 11 subjects had hypotension 10%.
Other clinical features of the subjects with HEs are shown
in Table 1
The biochemical parameters of the subjects with DKA and
HHS are compared in Table 2.
The lower the duration of DM, the higher the recorded
number of HEs admissions and deaths. A large majority -
89 (80%)- of the study subjects had short term duration
of DM and the highest number of deaths-18 deaths-were
recorded in this category of patients. The lowest number
of admissions and deaths (7 and 1 respectively) were
noted in subjects with long term duration of DM.
The morbidity pattern of hyperglycaemic emergencies is
such that the greatest number of DKA and HHS related
hospitalizations were recorded in the study subjects who
were middle aged (62 (66%) vs 9 (53%).
Previously undiagnosed DM and poor drug compliance
are responsible for over 50% of the precipitants of the
hyperglycaemic emergencies. The precipitants of HEs are
shown in Table 3.
The mortality data showed that 23 of the subjects hospi-
talized with HEs died thus giving a mortality rate of 20%.
Case fatality rates for DKA and HHS were 18% and 35%
respectively. The male: female ratio of the HEs associated
mortalities was 0.9:1.
The proportions of subjects with type 1 and type 2 DM
that died were 6 (29%) and 17 (18%) respectively.
The major prognostic factors for hyperglycaemic emergen-
cies' associated deaths include diabetes foot ulceration
(DMFS) and low duration of DM. Other predictive factors
for HEs associated mortality are shown in Table 4.
Discussion
Hyperglycaemic emergencies are oft encountered DM
complications in clinical practice. They are the most seri-
ous acute metabolic complications of diabetes mellitus
and are associated with excess mortality. The incidence of
DKA in the United States of America is 4.6 and 8.0 per
1000 person-years among patients with diabetes, whereas
that of HHS is less than 1 per 1000 person-years[10]. In
sub-Saharan Africa data on incidence rates for the HEs are
scarce. An earlier report by Ogbera et al[3] showed that Table 1: Clinical characteristics of the subjects with 
hyperglycaemic emergencies
DKA HHS P VALUE
Age 53.9(14.1) 54.1 (16.3) >0.05
Sex (F:M) 41:53 11:6 0.001
Mean blood glucose 22.8 (5.9) 38.3 (3.7) 0.00001
Presence of HTN 29 (31%) 5 (30%) >0.05
Altered mentation 18(19%) 8 (47%)
Seizures 0 3(17%)
DM duration 7 (9.8) 5.4 (7.3) >0.05
Table 2: Biochemical features of Hyperglycaemic emergencies
DKA HHS
Elevated urea levels 54 (57.4%) 9 (53%)
Hypernatraemia 2 (2%) 2 (12%)
Hypokalaemia 33 (35%) 8 (47%)
Hyponatraemia 18 (19%) 3 (18%)
The biochemical parameters of the subjects with DKA and HHS are 
compared in this table.BMC Endocrine Disorders 2009, 9:9 http://www.biomedcentral.com/1472-6823/9/9
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hyperglycaemic emergencies account for 40% of all DM
related hospitalization with a preponderance of DKA
admissions compared to that of HHS.
Hyperglycaemic emergencies occur in all age groups of
people with DM and in this report we found that DKA and
HHS admissions were recorded more in the 36–64 years
age bracket while the least number of DKA and HHS hos-
pitalizations were found in those below 35 years of age.
This study documented the mean age of subjects with HEs
to be 54 years and this is lower than those reported from
some Western, Asian sub-Saharan African countries [11-
13]. In this report, the mean ages of subjects presenting
with DKA and HHS [10,11] were comparable and these
findings are diametrically opposed to some other
reports[11,14] that showed a significant difference in the
ages of people presenting with HHS and DKA. The noted
difference between these reports and ours may be due to
our inability to assess the C-peptide levels which would
have helped in objectively classifying patients properly
according to DM type. Of note in this report, is that gender
was comparable in subjects presenting with HHS and
those presenting in DKA.
Though precipitating factors for HEs are varied, infections,
poor drug compliance and undiagnosed or new onset dia-
betes are factors that have consistently been reported as
being associated with HEs [5,11]. Although our findings
are consistent with the aforestated scenario, it is pertinent
to note that poor drug compliance was a major precipitant
of HEs in our study subjects. Documented reasons for
poor drug compliance in our patients ranged from poor
accessibility to health facilities, high costs of drugs often
resulting from polypharmacy because of co-morbidities
and also ignorance on self care habits of DM. Reported
rates of undiagnosed diabetes presenting as HEs range
from 10.9%–50%[7,11,12,15]. In this report undiag-
nosed DM accounted for 15% of the hyperglycaemic
emergencies.
The low prevalence of hypertension of DM in our patients
with type 2 DM may be explained by the fact the that
some of the subjects were not previously known to have
DM or hypertension and the presence of resultant hypo-
tension from hyperglycaemic emergencies may mask the
presence of hypertension. The mean age of our study pop-
ulation–may also partly explain the documented low
prevalence of hypertension in this clinical scenario as age-
ing is associated with hypertension.
The duration of DM was associated with mortality out-
comes as higher mortality rates were found in subjects
with low duration of DM. Previously undetected cases of
DM presenting in HEs may partly explain why this is so,
since this group of patients fall under the low duration of
DM category.
Electrolyte imbalances are the consequences of hyperglyc-
emia, hyperosmolality, and acidosis. The biochemical
parameters noted in this study were those of hypokalae-
mia. hyponatraemia, hypernatraemia and azotaemia and
hyperkalaemia. These abnormalities occurred more in
people with DKA except for hypernatraemia (HN) and
hypokalaemia (HP) which occurred in higher percentages
of subjects with HHS viz (12%,47% in HHS vs 2%,35% in
DKA). Hypokalemia was the prevalent form of electrolyte
imbalance observed in this Report. Hypokalaemia occurs
as a a result of urinary losses in the face of a high osmotic
gradient. Hyponatraemia, which was noted in about a
third of subjects with types 1 and 2 DM often result from
urinary losses and may be dilutional as water shifts extra-
cellularly because of high serum osmolarity. Not surpris-
ing, serum hyperkalemia was seen only in a few patients
and it's presence is explained by a shift of potassium from
the intracellular to extracellular space because of acidosis
from insulin deficiency and decreased renal tubular secre-
tion. Azotemia which may be a resultant effect of volume
contraction in patients with HEs was not objectively
assessed as only urea levels of these patients were docu-
mented. However the presence of elevated urea levels was
a prominent feature in our study subjects. Hypernatrae-
mia, a rare feature of the HEs especially DKA may signify
a response to reduction in circulating volume. The pres-
ence of hypotension, altered mentation and seizures in
this report were infrequent occurring in 11 (10%),
26(23%) and 3(3%) of the subjects with HEs respectively.
Table 3: Precipitants of hyperglycaemic emergencies
Precipitating factor No(Frequency)
Poor drug compliance 49 (44.1%)
Undiagnosed DM 15 (13.5%)
*DMFS 20 (18%)
**CVA 9(8.1%)
Sepsis 15 (13.5%)
≠ TDHS 3 (2.8%)
*diabetes mellitus foot syndrome,
**cerebrovascular accident,
≠ tropical diabetes hand syndrome
Table 4: Predictive factors for hyperglycaemic emergencies 
fatality
Variable Odds ratio 95% CI
DMFS 2.9 0.86–9.68
Elderly 1.3 0.3–4.1
Hypokalaemia 0.5 0.2–1.6
Hypertension 0.3 0.1–0.9
Sepsis 3.2 0.6–16.7
Low duration of DM 1.7 0.1–16.0BMC Endocrine Disorders 2009, 9:9 http://www.biomedcentral.com/1472-6823/9/9
Page 5 of 5
(page number not for citation purposes)
Seizures often occur in up to 25 percent of patients with
hyperosmolar non ketotic state and may be generalized,
focal, myoclonic jerking, or movement induced[16]. In
this report, seizures not surprisingly occurred only in sub-
jects with HHS. Hyperglycaemic emeregencies often are
associated with very high mortality in sub-Saharan Africa,
both in the treated patients and those who are presenting
to hospital with diabetes for the first time[6]. The overall
mortality rate of the HEs in this study was 20% and this
figure is lower than those noted in some sub-Saharan Afri-
can and Asian reports[7,12,15,17]. Mortality rates of HEs
from sub-Saharan Africa and Asia range from 30–44%
[7,11,14,16-19]. MacIssac et al [14] reported overall mor-
tality rates of HEs as low as 4.8%. The estimated mortality
rate for DKA range between 5–10% and that for HHS var-
ies from 10 to 50%[10]. In this study, the case fatality of
HHS at 35% was about twice that of DKA which was 18%.
Our findings are in consonance with the general findings
of higher case fatality rates of HHS compared with those
of DKA [13,14]. Some of the predictive factors for fatal
outcomes of the HEs in this report were sepsis, diabetes
foot ulceration, low duration of DM and being elderly.
The results from this report with regards to classification
into types 1 and 2 should be interpreted with caution
since objective classification of DM into these two types
requires the assessment of C-Peptide levels which was not
done.
Limitations of the Study
1. We were unable to assess C peptide levels and this was
as a result of financial constraints.
Conclusion
Hyperglycaemic emergencies remain a major cause of
concern in Nigerians with DM. Some of the determinants
of fatal outcomes include DM foot ulcers, hypokalaemia
and sepsis. These prognostic factors are readily modifiable
and these should be focus points for health care providers.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
AO conceived of the study, participated in its design,
acquisition of funding, drafting of manuscript and statis-
tical analysis. JA contributed to study design and statistical
analysis and acquisition of funding. CU contributed to
drafting of manuscript and study design. OF participated
in data collation and statistical analysis. All authors read
and approved the final manuscript.
Acknowledgements
I wish to acknowledge Dr F Ogbera who helped in proof reading and also 
providing funding for the work and Mrs E Ogunleye who helped in data col-
lation. Funding was largely "out of pocket". All sources of funding for this 
study were personal.
References
1. Engelgau MM, Narayan KM, Saaddine JB, Vinicor F: Addressing the
burden of diabetes in the 21st century: better care and pri-
mary prevention.  J Am Soc Nephrol 2003:S88-91.
2. Zimmet P: The burden of type 2 diabetes: are we doing
enough?  Diabetes Metab 2003, 29:6S9-18.
3. Ogbera AO, Chineneye S, Onyekwere A, Fasanmade O: Prognostic
Indices of DM mortality.  Ethn Dis 2007, 17(4):721-725.
4. Kitabchi AE, Wall BM: Management of diabetic ketoacidosis.
American Family Physician 1999, 60:2.
5. Umpierrez GE, Kitabchi AE: Diabetic ketoacidosis: risk factors
and management strategies.  Treat Endocrinol 2003, 2:95-108.
6. Otieno CF, Kayima JK, Omonqe EO, Oyoo JO: Diabetic ketoaci-
dosis: risk factors, mechanisms and management strategies
in sub-Saharan Africa: a review.  East Afr Med J 2005, 82(12
Suppl):S197-203.
7. Mbugua PK, Otieno CF, Kayima JK, Amayo AA, McLigeyo SO: Dia-
betic ketoacidosis:clinical presentation and precipitating fac-
tors at Kenyatta National Hospital, Nairobi.  East Afr Med J
2005, 82(12):S184-190.
8. Stoner Gregg D: Hyperosmolar, Hyperglycaemic State.  Ameri-
can Family Physicians 2005, 71:1624-1628.
9. Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA: Hyperglyc-
emic crises in adult patients with diabetes. A consensus
statement from the American Diabetes Association.  Diabetes
Care 2006, 29:2739-2748.
10. Fishbein H, Palumbo PJ: Acute metabolic complications in dia-
betes.  In Diabetes in America 2nd edition. Edited by: Harris MI, Cowie
CC, Stern MP, et al. Bethesda (MD) National Diabetes Data Group,
National Institutes of Health, National Institute of Diabetes and
Digestive and Kidney Diseases, NIH Publication No. 95-1468;
1995:283-292. 
11. Chu CH, Lee JK, Lam HC, Lu CC: Prognostic factors of hyperg-
lycaemic hyperosmolar nonketotic state.  Chang Gung Med J
2001, 24(6):345-351.
12. Rolfe M, Ephraim GG, Lincoln DC, Huddle KR: Hyperosmolar non-
ketotic diabetic coma as a cause of emergency hyperglycae-
mic admission to Baragwanath Hospital.  S Afr Med J 1995,
85(3):173-176.
13. Chung ST, Perue GG, Johnson A, Younger N, Hoo CS, Pascoe RW:
Predictors of hyperglycaemic crises and their associated
mortality in Jamaica.  Diabetes Res Clin Pract 2006, 73(2):184-190.
14. MacIsaac RJ, Lee LY, McNeil KJ, Tsalamandris C, Jerums G: Influence
of age on the presentation and outcome of acidotic and
hyperosmolar diabetic emergencies.  Intern Med J 2002,
32(8):379-385.
15. Jabbar A, Farooqui K, Habib A, Islam N, Haque N, Akhter J: Clinical
characteristics and outcomes of diabetic ketoacidosis in
Pakistani adults with Type 2 diabetes mellitus.  Diabetic Medi-
cine 2004, 21(8):920-923.
16. Delaney MF, Zisman A, Kettyle WM: Diabetic ketoacidosis and
hyperglycemic hyperosmolar nonketotic syndrome.  Endocri-
nol Metab Clin North Am 2000, 29:683-705.
17. Matoo VK, Nalini K, Dash RJ: Clinical profile and outcome of dia-
betic ketoacidosis.  J Assoc Physicians India 1991, 39(5):379-381.
18. Pinies JA, Cairo G, Gaztambide S, Vazquez JA: Course and progno-
sis of 132 patients with diabetic non ketotic hyperosmolar
state.  Diabete Metab 1994, 20(1):43-48.
19. Zouvanis M, Pieterse AC, Sefiel HC, Joffe BI: Clinical characteris-
tics and outcome of hyperglycaemic emergencies in Johan-
nesburg Africans.  Diabet Med 1997, 14(7):603-606.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6823/9/9/prepub  